<- Go Home

SofWave Medical Ltd.

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. It also provides technical and clinical product support services. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.

Market Cap

ILS 536.6M

Volume

35.3K

Cash and Equivalents

ILS 34.8M

EBITDA

ILS 7.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

ILS 66.0M

Profit Margin

75.27%

52 Week High

ILS 15.78

52 Week Low

ILS 5.43

Dividend

N/A

Price / Book Value

16.60

Price / Earnings

106.11

Price / Tangible Book Value

16.60

Enterprise Value

ILS 503.0M

Enterprise Value / EBITDA

57.97

Operating Income

ILS 6.9M

Return on Equity

19.17%

Return on Assets

8.69

Cash and Short Term Investments

ILS 34.8M

Debt

ILS 1.1M

Equity

ILS 32.7M

Revenue

ILS 87.6M

Unlevered FCF

ILS 13.3M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches